Irish Osteoporosis Policy

Cross-source consensus on Irish Osteoporosis Policy from 1 sources and 5 claims.

1 sources · 5 claims

Benefits

The findings support creating a national osteoporosis policy and clinical programme in Ireland. — Osteoporosis treatment gap and prescribing patterns in Ireland: a cross-sectional analysis of the DXA HIP project
The study identifies undertreatment of high-risk patients and overtreatment of low-risk or treatment-ineligible patients as simultaneous quality problems. — Osteoporosis treatment gap and prescribing patterns in Ireland: a cross-sectional analysis of the DXA HIP project
The study argues osteoporosis is not currently treated as a national priority in Ireland. — Osteoporosis treatment gap and prescribing patterns in Ireland: a cross-sectional analysis of the DXA HIP project
Ireland is projected to face major increases in osteoporosis-related fracture incidence and care costs. — Osteoporosis treatment gap and prescribing patterns in Ireland: a cross-sectional analysis of the DXA HIP project
A national programme could improve prescribing accuracy, reduce waste, and improve value without necessarily increasing cost. — Osteoporosis treatment gap and prescribing patterns in Ireland: a cross-sectional analysis of the DXA HIP project